Reports for TEVA CANADA LIMITED

Company Name

TEVA CANADA LIMITED

Totals

Shortage reports

2684

Actual shortage: 240 (9%)
Anticipated shortage: 0 (0%)
Avoided shortage: 9 (0%)
Resolved: 2435 (91%)

Discontinuation Reports

250

To be discontinued: 3 (1%)
Discontinued: 247 (99%)
Reversed: 0 (0%)

Late reports

330 (11%)

Overdue reports

24 (10%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
TEVA-QUETIAPINE XR 400MG TABLET (EXTENDED-RELEASE) Resolved 2017-03-13 2017-10-11 1760
TEVA-MOXIFLOXACIN 400MG TABLET Resolved 2017-04-03 2017-10-10 5216
TEVA-5 ASA 400MG TABLET (ENTERIC-COATED) Resolved 2017-08-01 2018-05-11 17844
TEVA-ACYCLOVIR 400MG TABLET Resolved 2017-11-16 2018-11-09 29444
NOVO-PROFEN 400MG TABLET Resolved 2018-03-13 2018-05-30 42644
TEVA-ACEBUTOLOL 400MG TABLET Resolved 2018-05-22 2019-08-20 50029
TEVA-ACYCLOVIR 400MG TABLET Resolved 2019-08-22 2019-10-04 92137
TEVA-QUETIAPINE XR 400MG TABLET (EXTENDED-RELEASE) Resolved 2019-09-19 2019-10-04 94375
TEVA-5 ASA 400MG TABLET (ENTERIC-COATED) Resolved 2019-09-26 2019-10-04 94825
TEVA-IMATINIB 400MG TABLET Resolved 2020-02-07 2020-05-08 105576
TEVA-QUETIAPINE XR 400MG TABLET (EXTENDED-RELEASE) Resolved 2020-04-10 2020-06-04 111826
TEVA-QUETIAPINE XR 400MG TABLET (EXTENDED-RELEASE) Resolved 2020-07-16 2020-09-17 120485
TEVA-ACYCLOVIR 400MG TABLET Actual shortage 2020-08-20 2021-01-14 122712
TEVA-GABAPENTIN 400MG CAPSULE Resolved 2020-10-01 2020-10-30 125494
TEVA-MOXIFLOXACIN 400MG TABLET Resolved 2020-11-19 2021-03-04 128603
TEVA-QUETIAPINE XR 400MG TABLET (EXTENDED-RELEASE) Resolved 2020-12-17 2021-01-21 130291
TEVA-5 ASA 400MG TABLET (ENTERIC-COATED) Resolved 2021-01-28 2021-04-08 132672
TEVA-IMATINIB 400MG TABLET Resolved 2021-02-18 2021-03-11 134334
TEVA-QUETIAPINE XR 400MG TABLET (EXTENDED-RELEASE) Resolved 2021-03-18 2021-04-21 135980
TEVA-5 ASA 400MG TABLET (ENTERIC-COATED) Resolved 2021-05-06 2021-06-10 138904

Showing 1921 to 1940 of 2684

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
RATIO-ATORVASTATIN Discontinued 2018-10-17 2018-10-17 64626
RATIO-ATORVASTATIN Discontinued 2018-10-19 2018-10-19 64852
ACT CLOPIDOGREL Discontinued 2018-10-19 2018-10-19 65065
ACT TADALAFIL Discontinued 2018-10-22 2018-10-22 65284
ACT TADALAFIL Discontinued 2018-10-22 2018-10-22 65289
HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION Discontinued 2019-04-11 2019-04-11 81330
HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION Discontinued 2019-04-11 2019-04-11 81337
HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION Discontinued 2019-04-11 2019-04-11 81344
HYDROCORTISONE SODIUM SUCCINATE INJECTION Discontinued 2019-04-11 2019-04-11 81347
TEVA-RANITIDINE Discontinued 2020-02-13 2020-02-13 106136
TEVA-RANITIDINE Discontinued 2020-02-13 2020-02-13 106139
RATIO-SALBUTAMOL Discontinued 2020-02-13 2020-02-13 106151
GEMCITABINE FOR INJECTION Discontinued 2020-02-13 2020-02-13 106155
EPTIFIBATIDE INJECTION Discontinued 2020-02-13 2020-02-13 106170
LINEZOLID INJECTION Discontinued 2020-02-13 2020-02-13 106173
EPTIFIBATIDE INJECTION Discontinued 2020-02-13 2020-02-13 106176
TEVA-TRAVOPROST Z OPHTHALMIC SOLUTION 0.004% SOLUTION Discontinued 2020-01-21 2020-01-21 103788
TEVA-ECTOSONE 0.1% LOTION Discontinued 2023-12-05 2023-12-05 212526
PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION 0.375G 3G POWDER FOR SOLUTION Discontinued 2023-11-15 2023-11-15 210191
RATIO-TAMSULOSIN 0.4MG CAPSULE (SUSTAINED-RELEASE) Discontinued 2018-10-19 2018-10-19 64917

Showing 21 to 40 of 250